Elaine Siegfried, MD: There’s tremendous work going on, and a lot of it is driven by investment from pharmaceutical companies in creating better treatments. Prior to very recently we had a handful of ...

Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital, speaks on the inflammatory mechanisms of atopic dermatitis and risk of comorbidities in affected patients. Can you ...

The burden of atopic dermatitis (AD) -- for patients, their families, and society -- is vast and increasing. AD affects approximately 10% to 30% of children and 2% to 10% of adults in developed ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Lauren Ax, MSPAS, PA-C ...

BALLERUP, Denmark--(BUSINESS WIRE)--NOT FOR UK USE – NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today announced positive results from the Phase 2a Mechanism of ...

New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg ...

How do you know if your itchy, red, inflamed skin rash is atopic dermatitis or contact dermatitis? These two skin conditions can have similar symptoms, but different causes and triggers. You can have ...